Objectives: We sought to systematically review and meta-analyze the available data on the association between timing of antibiotic administration and mortality in severe sepsis and septic shock. Data Sources: A comprehensive search criteria was performed using a predefined protocol. Study Selection: Inclusion criteria: adult patients with severe sepsis or septic shock, reported time to antibiotic administration in relation to emergency department triage and/or shock recognition, and mortality. Exclusion criteria: immunosuppressed populations, review article, editorial, or nonhuman studies. Data Extraction: Two reviewers screened abstracts with a third reviewer arbitrating. The effect of time to antibiotic administration on mortality was based on current guideline recommendations: 1) administration within 3 hours of emergency department triage and 2) administration within 1 hour of severe sepsis/septic shock recognition. Odds ratios were calculated using a random effect model. The primary outcome was mortality. Data Synthesis: A total of 1,123 publications were identified and 11 were included in the analysis. Among the 11 included studies, 16 ,178 patients were evaluable for antibiotic administration from emergency department triage. Patients who received antibiotics more than 3 hours after emergency department triage (< 3 hr reference) had a pooled odds ratio for mortality of 1.16 (0.92-1.46; p = 0.21). A total of 11,017 patients were evaluable for antibiotic administration from severe sepsis/septic shock recognition. Patients who received antibiotics more than 1 hour after severe sepsis/shock recognition (< 1 hr reference) had a pooled odds ratio for mortality of 1.46 (0.89-2.40; p = 0.13). There was no increased mortality in the pooled odds ratios for each hourly delay from less than 1 to more than 5 hours in antibiotic administration from severe sepsis/shock recognition. Conclusion: Using the available pooled data, we found no significant mortality benefit of administering antibiotics within 3 hours of emergency department triage or within 1 hour of shock recognition in severe sepsis and septic shock. These results suggest that currently recommended timing metrics as measures of quality of care are not supported by the available evidence. (Crit Care Med 2015; 43:1907 -1915 ) Key Words: antibacterial agents; antibiotics; septic shock; severe sepsis; shock recognition; timing of antibiotics S evere sepsis and septic shock remain a major cause of emergency department (ED) visits and ICU admissions and are associated with significant morbidity, mortality, and healthcare costs (1, 2) . Previous studies have suggested improved outcomes with the implementation of a structured resuscitation, focusing largely on IV fluid resuscitation, timely broad-spectrum antibiotics, and vasopressor therapy (3) (4) (5) (6) (7) . Although some authors have suggested the primacy of timely antibiotics administration for improved mortality in severe sepsis and septic shock (8, 9) , previously published research evaluating the association of the time to antibiotic administration on outcomes has produced disparate results.
In 2006, Kumar et al (10) reported a 7.6% increase in mortality in patients with sepsis for each hourly delay after the onset of shock. Although subsequent studies have failed to demonstrate such substantial results, several studies have reported increased mortality associated with delays in antibiotic administration either from shock recognition or time from ED triage (8) (9) (10) . Other studies have not demonstrated any increase in mortality with delay of antibiotic administration based on triage time (11, 12) .
The most recent Surviving Sepsis Campaign (SSC) guidelines include specific recommendations regarding the timing of antibiotics: "The administration of effective IV antimicrobials within the first hour of recognition of septic shock (grade 1B) and severe sepsis without septic shock (grade 1C) should be the goal of therapy" (13) . Additionally, the SSC recommends a "sepsis bundle," which requires administration of broad-spectrum antibiotics within 3 hours from ED triage. The authors of the SSC guidelines note that achieving these goals may not be operationally feasible in some cases and acknowledge that previous research has shown that compliance with guidelines regarding antibiotic administration frequently is not achieved (12) (13) (14) . Despite these limitations, time to antibiotics administration has gained increasing focus as a potential metric for the quality of care of patients with severe sepsis and septic shock (15) .
To our knowledge, no previous study has pooled the available data to evaluate the impact of time to antibiotics on sepsis outcomes. Our objective was to perform a systematic review of the published literature and to meta-analyze the available data on the association between the timing of antibiotics and mortality in severe sepsis and septic shock.
METHODS
We developed and followed a comprehensive protocol and data collection instrument that followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (16) recommendations prior to the start of the study. As this was not a study of human subjects but rather a synthesis of the previously published literature, it was exempt from institutional review board approval. evaluated for relevant articles. Given an anticipated limited availability of high-quality clinical trials evaluating our stated objective, all study types, except those previously mentioned, were eligible for inclusion. If the time to antibiotics or mortality was not explicitly reported, the study was potentially eligible for inclusion pending author contact. The primary outcome was mortality.
Search Strategy

Study Selection
Two authors (S.A.S., J.P.) independently reviewed abstracts of all relevant studies yielded from the initial search. In cases of disagreement, a review of the full article was conducted and inclusion determined by a third reviewer (A.E.J.). The full article of each study passing the relevance screen was independently reviewed for eligibility by two authors (S.A.S., W.R.M.). In cases of disagreement, a third reviewer (A.E.J.) determined inclusion. Data abstraction was performed using a standard data collection form for each study identified for final inclusion. For articles that did not include complete data for inclusion in the meta-analysis portion, corresponding authors were contacted for additional information.
Quality assessment
Though there is limited validity of scoring nonrandomized control trials for quality (17) , we elected to utilize a scoring system to determine study quality, given the anticipated inclusion of multiple study types. Therefore, we developed predetermined a scoring system for all included studies based on commonly excepted measures of quality, with four categories were scored between 0 and 2 ( Table 1) .
Timing of antibiotic administration and Statistical analysis
The effect of time to antibiotic administration on mortality was assessed in two ways based on the SSC guideline recommendations (13): 1) antibiotic administration within 3 hours of hospital presentation/ED triage and 2) antibiotic administration within 1 hour of severe sepsis/septic shock recognition.
To assess the association between mortality and the time to antibiotics from triage, the antibiotic timing was categorized as within 3 hours of triage or 3 hours and longer from triage with the former used as the reference group. To evaluate association between mortality and the time from septic shock/severe sepsis recognition to antibiotic administration, the antibiotic timing was categorized as within 1 hour or more than 1 hour from shock/severe sepsis recognition. We also performed a sensitivity analysis of the effect of time to antibiotics from severe sepsis/shock recognition in hourly increments (1-2, 2-3, 3-4, 4-5, > 5 hr) using less than 1 hour as the reference group. Odds ratios (OR) and 95% CIs were calculated using a random effect model (18) . Publication bias was assessed using funnel and L'Abbe plots. Heterogeneity was assessed using Cochran Q test.
RESUlTS
Study Inclusion
Our comprehensive literature search yielded 1,123 publications for possible inclusion. Of these, 36 were deemed relevant and eligible for full review with good interrater agreement (98.5%) in those identified. After full review and adjudication, 18 articles were deemed potentially eligible for inclusion. Of these, nine contained data for meta-analysis and nine required author contact for clarification of the data. After author contact, two articles provided additional data, leaving 11 articles for the full metaanalysis ( Fig. 1) . A summary of reasons for exclusion at each stage of the analysis is shown in Table 2 . Of the 11 included articles, three contained only data for timing from triage, five contained only data for timing from severe sepsis/septic shock recognition, and three contained data for both time points. All of the studies included in the meta-analysis were considered moderate-to-high quality (> 4 points) by our quality score ( Table 3) .
Study Descriptions and analyses
A list of 18 studies potentially eligible for inclusion were systematically reviewed and summarized in tabular format for the study characteristics, main findings, justification for inclusion/exclusion in meta-analysis, and quality assessment and listed in Table 3 .
Six of the 11 included studies contained the necessary data on 16,178 patients for inclusion in the analysis of the effect of time to antibiotic administration from triage on mortality. A total of 10,208 patients receiving antibiotics within 3 hours of triage of whom 2,574 died and 5,970 patients receiving antibiotics in 3 or more hours after triage of whom 1,793 died. As seen in Figure 2 , the pooled OR for patients who received antibiotics 3 or more hours after triage was 1.16 (95% CI, 0.92-1.46; p = 0.21) as compared to those that received antibiotics within 3 hours of triage. No statistical heterogeneity (p = 0.09) or publication bias was observed.
Eight of the 11 studies contained the necessary data on 11,017 patients for inclusion in analysis of the effect of time to antibiotics administration from severe sepsis/septic shock recognition. A total of 3,335 patients were included in the within 1 hour of recognition group of whom 1,174 died and 7,682 patients received antibiotics in 1 or more hours after severe sepsis/shock recognition of whom 3,581 deaths. The pooled OR for patients who received antibiotics in more than 1 hour of severe sepsis/shock recognition was 1.46 (95% CI, 0.89-2.40; p = 0.13) compared with those who received antibiotics within 1 hour of severe sepsis/septic shock recognition (Fig. 2) . Although we did find statistical heterogeneity (p < 0.001), there was evidence of no publication bias. The total number of included patients from each study is listed in and more than 5 hours for further assessment of the effect of hourly delays to antibiotic administration from severe sepsis/ shock recognition. The groups contained 848 deaths of 2,318 patients in the less than 1-hour group, 471 deaths of 1,298 patients in the 1-to 2-hour group, 323 deaths of 853 patients in the 2-to 3-hour group, 245 deaths of 615 patients in the 3-to 4-hour group, 193 deaths of 453 patients in the 4-to 5-hour group, and 1,537 deaths of 2,386 patients in the more than 5-hour group. We observed no statistical significant increased mortality in the pooled ORs for each hourly incremental delay in antibiotic administration from severe sepsis/shock recognition ( Table 5 ).
DISCUSSION
The SSC international guidelines for the management of severe sepsis and septic shock recommend administering antibiotics within 1 hour of recognition and within 3 hours of ED triage (13) . Using the available published data, our results indicate that in patients with severe sepsis and septic shock, antibiotic administration within 3 hours of ED triage and/or within 1 hour of shock recognition is not associated with significant improvement in mortality. Our findings do not support the SSC guideline recommendations on timing of antibiotic administration and raise concern about the use of time to antibiotic administration as currently recommended as a specific metric of treatment quality in sepsis care (13) .
The recognition and treatment of severe sepsis and septic shock remain a complex and challenging burden for clinicians with a persistently high mortality rate (1, 2, 12) . In the past 15 years, research has suggested that an early structured approach to recognition and treatment of sepsis improves outcomes likely due to a combination of factors including heightened recognition or awareness, early reversal of microcirculatory or endothelial dysfunction, reversal of hypoperfusion, and/or eradication of infectious nidus (3) (4) (5) 7) . However, the results of studies focusing on the impact of timing of antibiotic administration have been inconsistent (8, 9, 11, 14, 19) .
While it is recognized that failure to administer effective antimicrobial therapy will at some time point be detrimental to patient outcomes, the exact time frame when this shift begins to occur remains unknown. Furthermore, no randomized clinical trials examine the impact of the timing of antibiotics on Figure 2 . Summary of forest plots. a, Pooled odds ratios for mortality and time to antibiotics in less than or more than 3 hr from triage time. b, Pooled odds ratios for mortality and time to antibiotics in less than or more than 1 hr from severe sepsis/shock recognition.
outcomes directly (20) , and for obvious reasons, it is unlikely any direct experimental investigation will be planned in the near future given current guideline recommendations and ethical concerns regarding patient safety of such a design (13) . Thus, our results represent the most comprehensive and robust analysis of the differentiation and true impact of timing of antibiotic administration on outcome during the earliest phases of sepsis care.
There are multiple potential explanations for our findings of no mortality benefit when antibiotics are given within 3 hours of triage or 1 hour of severe sepsis/septic shock recognition. First, given the complexity of the pathophysiologic insult of sepsis and resulting organ dysfunction, it is unlikely that a limited single point in time intervention, such as administration of a single dose of antibiotics, would have a profound and singular impact on survival. In fact, no other therapeutic agent has ever been shown to provide this effect despite many decades of research. As recently found in the Protocolized Care for Early Septic Shock trial, many of the aggressive interventions targeted over the last several years may not be as impactful as initially reported (21) . Second, it is plausible that in some patients, the initiation of resuscitation prior to the administration of antibiotics provides the most ideal circumstance for the host to have a sustained and robust hemodynamic response to the propagation of the inflammatory cascade and resultant insult that can be instigated by release of components during bacterial lysis (22) (23) (24) (25) .
Time to antibiotic administration is a logical and tempting metric to target when considering the quality of sepsis care. Venkatesh et al (12) examined whether using the SSC recommendation metric of 3 hours from ED triage to antibiotic administration could adequately characterize what is realized in practice. In this study, the triage-based metric performed poorly, misclassifying 23.4% of patients, likely due to the variable progression and clinical course in severe sepsis and septic shock. Furthermore, Villar et al (26) found that 15% of patients with documented severe sepsis and septic shock do not meet diagnostic criteria until more than 3 hours after hospital arrival. Both studies concluded that a triage-based metric was inadequate to evaluate ED performance in severe sepsis and septic shock and suggested that time to antibiotics from triage is not a reliable quality metric (12, 26) . Our results provide quantitative data to support these conclusions in that we found no mortality benefit when antibiotics were administered within 3 hours of triage or 1 hour of severe sepsis/septic shock recognition.
We believe that an incorrect interpretation of this report would be that early administration of antibiotics is not of substantial importance. Antimicrobial administration is largely considered the cornerstone therapy for bacterial infections and a mandatory component of the management of severe sepsis and septic shock. Rather, our results should serve to highlight the importance of data-driven and evidence-based metrics for measuring quality in the care of acute critical conditions, such as sepsis, rather than empiric, arbitrary, or nonevidence-based metrics that do not have patient-oriented outcome benefit, are not operationally feasible, and/or cannot be practically achieved in a comprehensive individual and systems change approach.
As a systematic review and meta-analysis of previously published literature, our results are limited by the inherent flaws and shortcomings of the included parent studies. Also, no randomized clinical trials have directly examined the effect of time to antibiotic administration on outcomes; our data were derived from cohort studies and different patient populations. While a randomized trial of immediate versus delay antibiotic administration would be difficult to design and implement, given the current variability of associative data, such a trial would be a substantial contribution to the current evidence base. Third, there was evidence of statistical heterogeneity among the included studies evaluating time to antibiotic administration from severe sepsis/shock recognition. While this is a limitation, given the large sample size in this study, the findings appear to be robust and maintain validity. Several publications appeared to have patient populations that had the potential to be included in our analysis but did not contain data that would allow for inclusion and analysis. We attempted author contact in these cases on three different occasions. We received responses in half of these requests and no response, either positive or negative, in half of requests. Although we followed recommended methodology for making valiant attempts to obtain all potential data for inclusion, it remains possible that their inclusion could have altered the results of this study and the lack of their inclusion heightens the possibility of information bias in our report. Finally, we did not limit our study to appropriate or effective antibiotics (defined as an identified organism with in vitro sensitivity to an administered antibiotic). This was an a priori decision and viewed by the authors as the most clinically relevant and valid approach. Our rational for this decision were as follows: 1) our primary aims were to evaluate the antibiotic recommendations of the SSC guidelines, which recommend that broad-spectrum antibiotics that are likely effective based on patient history and local antibiogram-resistant patterns, but do not specify that the antibiotics should be "appropriate" (i.e., sensitive to the subsequently cultured microbe); 2) including appropriateness of antibiotic choice into a meta-analysis would introduce irreconcilable clinical heterogeneity because undoubtedly the standard definition of appropriateness would vary greatly between articles, including deciding on which cultures to include, what constitutes a positive culture, and how to handle conditions in which cultures are expected to be negative (such as cellulitis); 3) half or more of sepsis cases are culture negative and information on the offending organism and sensitivities are almost never available to treating clinicians at the time of antibiotic choice and administration, often taking between 12 and 120 hours for bacterial speciation and sensitivities using traditional blood culture techniques (27, 28) . In a post hoc review of the studies included in the meta-analysis, several studies mentioned appropriate antibiotics, but only one contained usable population-level data on the effect of appropriate or effective antibiotics on mortality. Among the studies that mentioned appropriate antibiotic therapy, there were vast differences in definitions for appropriate or effective antibiotics, highlighting the clinical heterogeneity with this definition. Following are the some examples of the various definitions: a) One study included culture-negative shock, but guideline-adherent broad-spectrum antibiotics and for culturepositive patients, in vitro activity against causative organism. This article only evaluates those with appropriate antibiotics administered within 6 hours of first antibiotic treatment; b) one study reported only culture-positive patients, with appropriateness of antibiotics determined within 24 hours of diagnosis, not the initial dose of antibiotics; c) one study discussed but never defined appropriate antibiotics; d) one study defined local institutional antibiotic guideline adherence as appropriate regardless of culture results. Although we recognize that the impact of appropriate or effective antibiotics in the early resuscitation of severe sepsis and septic shock remains an important question, there do not appear to be data available for meta-analysis of this subgroup, and we suggest that future investigations should address this question with standard definitions and approaches.
CONClUSION
In this comprehensive analysis of pooled data from the available literature in patients with severe sepsis and septic shock, administration of antibiotics within 3 hours of ED triage or within 1 hour of recognition of severe sepsis/septic shock did not confer mortality benefit. These results suggest that currently recommended specific timing metrics in international guidelines are not supported by the currently available evidence. Future stakeholders should consider these data when developing metrics to measure quality of care in severe sepsis and septic shock.
